Downregulation of CD9 protein expression is associated with aggressive behavior of oral squamous cell carcinoma


Autoria(s): BUIM, Marcilei Eliza Cavicchioli; LOURENCO, Silvia Vanessa; CARVALHO, Katia Candido; CARDIM, Roberta; PEREIRA, Claudia; CARVALHO, Andre Lopes; FREGNANI, Jose Humberto; SOARES, Fernando Augusto
Contribuinte(s)

UNIVERSIDADE DE SÃO PAULO

Data(s)

19/10/2012

19/10/2012

2010

Resumo

Squamous cell carcinoma of the oral cavity (OSCC) is a malignancy characterized by a high degree of local aggression and metastasis to cervical lymph nodes. Tetraspanins are proteins with functional roles in a wide array of cellular processes and are reported to be associated with tumor progression. The present study investigated the expression of the CD9, CD37, CD63, CD81 and CD82 tetraspanins in OSCC using immunohistochemistry (IHC) and quantitative Real Time-PCR (qRT-PCR). Tissue microarray (TMA) analysis of samples from 179 cases of OSCC and 10 normal samples oral mucosa were evaluated immunomorphologically. We analyzed CD9 and CD82 expression by qRT-PCR in 66 OSCC cases and 4 normal samples of oral mucosa. Expression of CD63, CD37 and CD81 was not detected in the samples studied. CD82 was downregulated or negative in 127 of 179 (80%) specimens; no correlation was observed between CD82 expression, clinicopathological parameters, disease-free survival and 5-year overall survival. CD9 expression was downregulated or negative in 75 of 129 (42%) OSCC samples. Loss of CD9 expression in OSCC samples correlated with the incidence of lymph node metastasis (p = 0.017). Disease-free survival and the 5-year overall survival of patients with downregulated or negative CD9 expression were significantly lower than in patients with positive CD9 expression (p = 0.010 and p = 0.071, respectively). No correlation was found between CD9 or CD82 expression and clinicopathological parameters by qRT-PCR. Our results suggest that the downregulation or lack of expression of the CD9 protein might indicate a more aggressive of OSCC. (C) 2009 Elsevier Ltd. All rights reserved.

Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Brazil

Identificador

ORAL ONCOLOGY, v.46, n.3, p.166-171, 2010

1368-8375

http://producao.usp.br/handle/BDPI/25690

10.1016/j.oraloncology.2009.11.009

http://dx.doi.org/10.1016/j.oraloncology.2009.11.009

Idioma(s)

eng

Publicador

ELSEVIER SCIENCE BV

Relação

Oral Oncology

Direitos

restrictedAccess

Copyright ELSEVIER SCIENCE BV

Palavras-Chave #Tetraspanin #CD9 #CD82 #Oral squamous carcinoma #Immunohistochemistry #METASTASIS SUPPRESSOR GENE #LYMPH-NODE METASTASIS #TRANSENDOTHELIAL INVASION #KAI1/CD82 EXPRESSION #HIGH PREVALENCE #LUNG-CANCER #PROGRESSION #MOTILITY #KAI1 #MRP-1/CD9 #Oncology #Dentistry, Oral Surgery & Medicine
Tipo

article

original article

publishedVersion